TP53 and head and neck squamous cell carcinoma: In TCGA dataset, which includes 478 HNSCC molecularly well characterized cases we found that patients carrying TP53 mutation exhibited a significantly lower level of TMPRSS2 expression compared to the patients with intact TP53 gene (Fig. 2a).